GEN-XENE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Gen-xene, and what generic alternatives are available?
Gen-xene is a drug marketed by Alra and is included in three NDAs.
The generic ingredient in GEN-XENE is clorazepate dipotassium. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the clorazepate dipotassium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Gen-xene
A generic version of GEN-XENE was approved as clorazepate dipotassium by AUROBINDO PHARMA on July 17th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GEN-XENE?
- What are the global sales for GEN-XENE?
- What is Average Wholesale Price for GEN-XENE?
Summary for GEN-XENE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 26 |
| Patent Applications: | 339 |
| DailyMed Link: | GEN-XENE at DailyMed |
US Patents and Regulatory Information for GEN-XENE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alra | GEN-XENE | clorazepate dipotassium | TABLET;ORAL | 071787-001 | Apr 26, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alra | GEN-XENE | clorazepate dipotassium | TABLET;ORAL | 071788-001 | Apr 26, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alra | GEN-XENE | clorazepate dipotassium | TABLET;ORAL | 071789-001 | Apr 26, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
